Penumbra, Inc.
PEN
Xếp hạng trong cổ phiếu
#1677
Penumbra, Inc., together with its subsidiaries, designs, develops,... Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Giá cổ phiếu
$323.90
Vốn hóa thị trường
$12.76B
Thay đổi (1 ngày)
0.35%
Thay đổi (1 năm)
30.81%
Quốc gia
US
Giao dịch Penumbra, Inc. (PEN)
Danh mục
Healthcare
Tỷ lệ P/B của Penumbra, Inc. (PEN)
Tỷ lệ P/B vào October 2026 TTM: 8.22
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Penumbra, Inc., tỷ lệ P/B hiện tại (TTM) là 8.22. Vào cuối năm 2023, công ty có P/B là 8.19.
Lịch sử tỷ lệ P/B của Penumbra, Inc. từ 2012 đến 2026
Tỷ lệ P/B vào cuối mỗi năm
| Năm | Tỷ lệ P/B | Thay đổi |
|---|---|---|
| 2026 (TTM) | 8.22 | 3.16% |
| 2024 | 7.97 | -2.71% |
| 2023 | 8.19 | -2.78% |
| 2022 | 8.43 | -23.89% |
| 2021 | 11.07 | 13.49% |
| 2020 | 9.76 | -16.95% |
| 2019 | 11.75 | 12.49% |
| 2018 | 10.44 | 34.76% |
| 2017 | 7.75 | 6.29% |
| 2016 | 7.29 | 162.72% |
| 2015 | 2.78 | -103.39% |
| 2014 | -81.83 | -34.83% |
| 2013 | -125.56 | 0.00% |
| 2012 | 0.00 | 0.00% |
Tỷ lệ P/B của các công ty tương tự hoặc đối thủ cạnh tranh
| Công ty | Tỷ lệ P/B | Chênh lệch Tỷ lệ P/B | Quốc gia |
|---|---|---|---|
| 3.5116 | -57.29% |
US
|
|
| 2.0146 | -75.50% |
IE
|
|
| 4.5025 | -45.24% |
US
|
|
| 2.5486 | -69.00% |
US
|
|
| - | - |
DE
|
